OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis	212
Alginate-based aerogels as wound dressings for efficient bacterial capture and enhanced antibacterial photodynamic therapy	204
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice	197
Electroporation induced changes in extracellular vesicle profile	160
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity	157
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery	146
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice	141
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis	127
Immunomodulatory nano-preparations for rheumatoid arthritis	98
Recent progress in nanotechnology-based drug carriers for resveratrol delivery	95
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis	80
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation	79
Advanced hydrogel material for colorectal cancer treatment	75
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment	73
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility	69
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems	67
Correction	63
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model	63
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats	61
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach	60
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions	60
Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant	57
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics	56
Effect and mechanism of paclitaxel loaded on magnetic Fe ₃ O ₄ @mSiO ₂ -NH ₂	55
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions	54

Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques	54
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements	53
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms	53
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments	52
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management	52
Platinum-based drugs and hydrogel: a promising anti-tumor combination	51
Advance in placenta drug delivery: concern for placenta-originated disease therapy	50
Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption	49
Nanoparticles-based anti-aging treatment of Alzheimer’s disease	49
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin	47
Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis	47
SREKA-targeted liposomes for highly metastatic breast cancer therapy	47
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer	47
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective	46
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases	46
Application of chitosan-based drug delivery systems in the treatment of bacterial diseases: a review	46
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs	46
PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide	45
PEGylation technology: addressing concerns, moving forward	45
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers	45